• Mesoblast's Trial Data In AGVHD: An IOMachine Runthrough seekingalpha
    September 04, 2018
    When I think of Mesoblast (MESO), the negatives I have are: one, this company is based outside US so there’s that much less scrutiny, two, the hyperbole surrounding stem cells, as a Seeking Alpha contributor put it two years ago, and three, these serial a
PharmaSources Customer Service